Lymphocytes Archive - MS-Docblog

ECTRIMS 2021 (1): Vaccination against SARS-CoV2

20. October 2021 Prof. Dr. med. Mathias Mäurer General

This year, the ECTRIMS Congress was again held virtually due to the pandemic. While this was a pity, as large international congresses thrive on the personal exchange between doctors and scientists, there was still plenty

Gilenya – Lymphocyte Levels in Clinical Practice

22. September 2017 Prof. Dr. med. Mathias Mäurer General, MS Therapy

Lymphocyte levels also play an important role in monitoring the active substance Fingolimod (Gilenya). However, the considerations here are quite different from those for Dimethyl fumarate (Tecfidera – Lymphocyte levels in clinical practice from March

Tecfidera – Lymphocyte Levels in Clinical Practice

30. March 2017 Prof. Dr. med. Mathias Mäurer General

In my previous post, I wrote about the basic importance of the small blood count and the differential blood count (“complete blood count”) – I therefore refer to this article for a better understanding of

Small Excursion: The White Blood Cells

10. March 2017 Prof. Dr. med. Mathias Mäurer General

We often talk in the MS clinic about white blood cells, about leukocytes, lymphocytes, granulocytes and what they’re all called. But I always find that the background knowledge about these important cells is often incomplete,

First PML Case under Tecfidera

6. March 2015 Prof. Dr. med. Mathias Mäurer General

This case is not exactly new – to be precise, the news came out in October 2014 – nevertheless, I keep hearing inquiries about the situation, which is why I would like to briefly comment

Tag: Lymphocytes

ECTRIMS 2021 (1): Vaccination against SARS-CoV2

Gilenya – Lymphocyte Levels in Clinical Practice

Tecfidera – Lymphocyte Levels in Clinical Practice

Small Excursion: The White Blood Cells

First PML Case under Tecfidera

Thank You!

Recent Posts

Archive

Categories

Links

Follow us

The Expert

The Topics

The Community